
From Tuesday, biotech company Orphazyme’s current CFO, Anders Vadsholt, will be the company’s CEO.
Vadsholt will therefore begin spearheading Orphazyme a month earlier than the previously announced timeline.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app